Corticosteroid_NN
receptors_NNS
and_CC
lymphocyte_NN
subsets_NNS
in_IN
mononuclear_JJ
leukocytes_NNS
in_IN
aging_NN
._.

Plasma_NN
cortisol_NN
and_CC
aldosterone_NN
levels_NNS
and_CC
number_NN
of_IN
related_JJ
receptors_NNS
in_IN
mononuclear_JJ
leukocytes_NNS
were_VBD
measured_VBN
in_IN
49_CD
healthy_JJ
aged_JJ
subjects_NNS
-LRB-_-LRB-
62-97_CD
yr_NN
-RRB-_-RRB-
and_CC
in_IN
21_CD
adult_JJ
controls_NNS
-LRB-_-LRB-
21-50_CD
yr_NN
-RRB-_-RRB-
._.

In_IN
all_DT
subjects_NNS
,_,
in_IN
addition_NN
,_,
lymphocyte_NN
subsets_NNS
were_VBD
determined_VBN
as_IN
an_DT
index_NN
of_IN
corticosteroid_NN
action_NN
._.

The_DT
mean_JJ
number_NN
of_IN
type_NN
I_CD
and_CC
type_NN
II_CD
receptors_NNS
was_VBD
significantly_RB
lower_JJR
in_IN
aged_JJ
subjects_NNS
than_IN
in_IN
controls_NNS
-LRB-_-LRB-
respectively_RB
,_,
198_CD
+_CC
\/_JJ
-_:
96_CD
and_CC
272_CD
+_NN
\/_:
-_:
97_CD
receptors\/cell_NNS
for_IN
type_NN
I_NN
,_,
and_CC
1,794_CD
+_CC
\/_JJ
-_:
803_CD
and_CC
3,339_CD
+_CC
\/_JJ
-_:
918_NN
for_IN
type_NN
II_CD
receptors_NNS
-RRB-_-RRB-
._.

Plasma_NN
aldosterone_NN
and_CC
cortisol_NN
and_CC
lymphocyte_NN
subsets_NNS
were_VBD
not_RB
different_JJ
in_IN
the_DT
two_CD
groups_NNS
._.

All_DT
of_IN
the_DT
parameters_NNS
were_VBD
also_RB
tested_VBN
for_IN
correlation_NN
,_,
and_CC
a_DT
significant_JJ
inverse_JJ
correlation_NN
was_VBD
found_VBN
between_IN
age_NN
and_CC
type_NN
I_NN
and_CC
type_NN
II_CD
receptors_NNS
when_WRB
all_DT
subjects_NNS
were_VBD
plotted_VBN
and_CC
between_IN
aged_JJ
and_CC
CD4_NN
and_CC
age_NN
and_CC
CD4\/CD8_NN
in_IN
the_DT
aged_JJ
group_NN
._.

These_DT
data_NNS
show_VBP
that_IN
aged_JJ
subjects_NNS
have_VBP
reductions_NNS
of_IN
corticosteroid_NN
receptors_NNS
that_WDT
are_VBP
not_RB
associated_VBN
with_IN
increase_NN
of_IN
related_JJ
steroids_NNS
and_CC
that_IN
this_DT
situation_NN
probably_RB
represents_VBZ
a_DT
concomitant_NN
of_IN
the_DT
normal_JJ
aging_NN
process_NN
._.

